Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock Discusses New CRISPR IP Alliance

December 19, 2016  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Some Consensus in the CRISPR Patent Case,” an article published in MedCity News. The article discuses four companies founded in the CRISPR space that announced last Friday, December 16, that they had formed an IP alliance.

Read the article here

 

Related Links

Industries

News & Insights

News
May 2026
In Law360 Interview, Philip Nelson Discusses Subject Matter Eligibility Declarations in USPTO Patent Application Process
In the Law360 article “How Patent Eligibility Declarations Can Stave Off Rejection,” Knobbe Martens partner Philip Nelson discussed the practical impacts of the U.S. Patent and Trademark Office’s recent update...
Publications
May 2026
Joshua Martineau and Jarom Kesler Explore New USPTO Procedure for Ex Parte Reexamination in Law360
In a recent article published in Law360, Knobbe Martens lawyers Joshua Martineau and Jarom Kesler explore the U.S. Patent and Trademark Office (USPTO)’s latest guidance regarding ex parte reexamination (EPR)...
Publications
May 2026
USPTO Launches PIER Pilot Program Creating New Pre-Examination Decision Point for PCT National Stage Applications
Key Takeaway: The USPTO’s new PIER Pilot Program requires applicants in selected PCT national stage applications to affirmatively decide whether to proceed with, delay, or abandon U.S. patent examination. Participation...